RNAZ TRANSCODE THERAPEUTICS INC Product Launches 8-K Filing 2024 - Clinical Trial Update Transcode Therapeutics announced the approval to open a third cohort and shared preliminary results from the first cohort of its Phase 1 TTX-MC138 clinical trial, highlighting the potential of microRNAs in cancer treatment.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC